Share chart Aadi Bioscience, Inc.
Extended chart
Simple chart
About Aadi Bioscience, Inc.
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus bound to albumin. The company is also involved in evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.| IPO date | 2017-08-08 |
|---|---|
| ISIN | US00032Q1040 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://aadibio.com |
| Цена ао | 2.2 |
| Change price per day: | +3.55% (3.1) |
|---|---|
| Change price per week: | -5.31% (3.39) |
| Change price per month: | +40.79% (2.28) |
| Change price per 3 month: | +66.32% (1.93) |
| Change price per half year: | +143.18% (1.32) |
| Change price per year: | +58.91% (2.02) |
| Change price per 3 year: | -87.57% (25.82) |
| Change price per 5 year: | +504.41% (0.5311) |
| Change price per 10 year: | 0% (3.21) |
| Change price per year to date: | +61.31% (1.99) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Avoro Capital Advisors LLC | 2849402 | 11.6 |
| Acuta Capital Partners LLC | 1849402 | 7.53 |
| Alerce Investment Management, L.P. | 1630830 | 6.64 |
| Blackrock Inc. | 1081631 | 4.41 |
| Vanguard Group Inc | 859697 | 3.5 |
| Decheng Capital LLC | 526329 | 2.14 |
| Decheng Capital Management III (Cayman), LLC | 526329 | 2.14 |
| Morgan Stanley | 510671 | 2.08 |
| Vivo Capital, LLC | 509572 | 2.08 |
| Citadel Advisors Llc | 407722 | 1.66 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.00821 | 17.09 | 1.54048 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Dr. Neil P. Desai Ph.D. | Founder & Executive Chairman | 710.35k | 1965 (60 years) |
| Dr. Loretta M. Itri F.A.C.P., M.D. | Chief Medical Officer | 617.45k | 1950 (75 years) |
| Mr. David J. Lennon Ph.D. | President, CEO & Director | 277.75k | 1971 (54 years) |
| Mr. Scott M. Giacobello CPA | CFO, Treasurer, Investor Relations & Corporate Communications | 643.23k | 1970 (55 years) |
| Mr. Stephen M. Rodin J.D. | Senior VP of Legal & General Counsel | N/A | 1976 (49 years) |
| Mr. Raymond G. Steitz | Senior VP of Human Resources & Chief Human Resources Officer | N/A | 1959 (66 years) |
| Mr. Bryan Ball | Chief Technical Operations Officer | N/A | 1970 (55 years) |
Address: United States, Pacific Palisades. CA, 17383 Sunset Boulevard - open in Google maps, open in Yandex maps
Website: https://aadibio.com
Website: https://aadibio.com
